- Home
- TECX vs MSB Comparison
TECX vs MSB Comparison
Compare TECX & MSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- MSB
- Stock Information
- Founded
- TECX 2019
- MSB 1961
- Country
- TECX United States
- MSB United States
- Employees
- TECX N/A
- MSB N/A
- Industry
- TECX
- MSB Metal Mining
- Sector
- TECX
- MSB Basic Materials
- Exchange
- TECX Nasdaq
- MSB Nasdaq
- Market Cap
- TECX 334.4M
- MSB 332.3M
- IPO Year
- TECX 2018
- MSB N/A
- Fundamental
- Price
- TECX $21.09
- MSB $24.24
- Analyst Decision
- TECX Buy
- MSB
- Analyst Count
- TECX 6
- MSB 0
- Target Price
- TECX $78.67
- MSB N/A
- AVG Volume (30 Days)
- TECX 243.5K
- MSB 33.5K
- Earning Date
- TECX 08-13-2025
- MSB 01-01-0001
- Dividend Yield
- TECX N/A
- MSB 28.58%
- EPS Growth
- TECX N/A
- MSB 335.65
- EPS
- TECX N/A
- MSB 7.12
- Revenue
- TECX N/A
- MSB $25,894,592.00
- Revenue This Year
- TECX N/A
- MSB N/A
- Revenue Next Year
- TECX N/A
- MSB N/A
- P/E Ratio
- TECX N/A
- MSB $3.36
- Revenue Growth
- TECX N/A
- MSB N/A
- 52 Week Low
- TECX $13.70
- MSB $15.93
- 52 Week High
- TECX $61.07
- MSB $37.00
- Technical
- Relative Strength Index (RSI)
- TECX 50.45
- MSB 45.95
- Support Level
- TECX $19.13
- MSB $23.45
- Resistance Level
- TECX $20.75
- MSB $25.41
- Average True Range (ATR)
- TECX 1.33
- MSB 0.97
- MACD
- TECX -0.10
- MSB 0.03
- Stochastic Oscillator
- TECX 56.73
- MSB 41.10
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
About MSB Mesabi Trust
Mesabi Trust operates as a royalty trust in the United States. The company is involved in the conservation and protection of its assets. The company's principally wholly-owned segment is the iron ore mining segment, which generates income from the Peter Mitchell Mine, an iron mine located near Babbitt, Minnesota, at the eastern end of the Mesabi Iron Range.